Aching Along the Back-Outer Knee After Downhill Running — Don’t Mistake Popliteus Tendinopathy for Knee Osteoarthritis or a Lateral Meniscus Tear: Dr. Moriwaki on What Peri-Articular Stem Cell Conditioned Media Injection Can and Cannot Do2026.08.06

“When I run downhill, only the back-outer part of my knee starts to ache.” “On a flat straight, nothing hurts — but the moment I hit trails or descending stairs, symptoms appear.” I meet these runners and hiking enthusiasts in the clinic quite often. Many of them arrive worried — “Is this knee osteoarthritis?” “Have I torn my lateral meniscus?” But when the pain is pinpointed to the postero-lateral knee, the problem is often not inside the joint cavity at all. It is chronic tendon and enthesis pathology — popliteus tendinopathy — sitting around the joint. In this article Dr. Moriwaki of AVAN TOKYO Ginza organizes the pathology of popliteus tendinopathy and honestly draws the line between what a peri-articular knee injection of stem cell conditioned media can address and what it cannot.

Key points of this article

・Popliteus tendinopathy produces a dull ache at the postero-lateral knee during downhill running or speed-control situations and is often mistaken for knee osteoarthritis or a lateral meniscus tear.

・The pathology sits around the knee joint — in the tendon and its enthesis — rather than inside the joint cavity itself.

・A peri-articular stem cell conditioned media injection can target the chronic inflammatory environment around the popliteus tendon, but it does not repair a complete tear of the tendon or structural injury of the posterolateral corner.

・Diagnosis comes first: rule out posterior horn lateral meniscus tears, posterolateral corner (PLC) injuries and lateral-compartment knee osteoarthritis before designing treatment.

・Do not stop at injections — running-load management, lower-limb alignment work and physical therapy must proceed in parallel.

What is popliteus tendinopathy — reading the pathology from postero-lateral knee anatomy

The popliteus is a small muscle that originates on the lateral femoral condyle and attaches to the upper posterior surface of the tibia. During early knee flexion it internally rotates the tibia slightly, unlocking the extended knee. Its tendon has both an intra-articular portion passing through the capsule and an extra-articular portion, and it maintains close relationships with the lateral meniscus and the lateral collateral ligament (LCL). Because of this anatomy, when the popliteus tendon is loaded chronically, several problems appear together: degeneration of the tendon substance itself (tendinosis), chronic inflammation of the enthesis (enthesitis), and irritation of the peri-tendinous synovial tissue. Downhill running concentrates one-directional eccentric loading on the popliteus muscle-tendon unit as it decelerates flexion and controls tibial rotation, and popliteus tendinopathy is well recognized in that context. It is more accurate to describe it as chronic overload at an anatomically vulnerable site than as simple “overuse.”

How to distinguish it from knee osteoarthritis and lateral meniscus injury

Because postero-lateral knee pain is a shared symptom of several conditions, physical examination and imaging must come first. In lateral-compartment knee osteoarthritis (typically with a valgus tendency) the pain is loaded-based and shows up broadly with walking or standing, and “only when going downhill” is not the usual pattern. Lateral meniscus injury — especially the posterior horn — is provoked by squatting, extension from the flexed position, and cutting movements, sometimes with a catching sensation. Popliteus tendinopathy, by contrast, reproduces symptoms on descending running, produces localized tenderness posterior to the lateral femoral condyle where the popliteus tendon runs, and provokes pain with resisted knee flexion combined with tibial internal rotation. MRI may show increased peri-tendinous signal, thickening or a partial tear, but chronic micro-degeneration is not always captured by standard MRI protocols, so clinical findings and symptom pattern carry weight. For information about joint disease you can also refer to the Japanese Orthopaedic Association.

What peri-articular stem cell conditioned media injection can target

For popliteus tendinopathy, a peri-articular knee injection of stem cell conditioned media aims strictly at recalibrating the chronic inflammatory environment around the tendon and its enthesis. The growth factors and cytokines in stem cell conditioned media — TGF-β, IGF-1, FGF and others — are thought to contribute to the modulation of inflammatory mediators and the baseline cellular responses that support tissue repair. Tendons and entheses have limited blood supply and are inherently slow to heal; when repeated mechanical stress outpaces self-repair, the condition becomes chronic. Popliteus tendinopathy is a textbook example. Steroid injections aimed solely at suppressing inflammation may act only briefly, and repeated use has been associated with tendon weakening. A peri-articular stem cell conditioned media injection is a design choice that seeks anti-inflammatory action and repair-friendly conditions simultaneously. That said, we never promise “guaranteed cure” or “complete resolution in a short period” — we always explain up front that response varies between individuals and that there are limits to what can be achieved.

What peri-articular stem cell conditioned media injection cannot target

On the other side, some situations are outside what a peri-articular injection can address, or call for great caution. First, a complete tear of the popliteus tendon or a severe injury of the posterolateral corner (PLC) is a structural failure of ligament-tendon continuity — not something an injection can restore. Orthopaedic ligament reconstruction takes precedence. Second, for a symptomatic large lateral meniscus tear with a flap-shaped fragment, arthroscopic partial meniscectomy or repair is prioritized. Third, in end-stage lateral-compartment knee osteoarthritis with advanced varus or valgus deformity, even calming the peri-articular inflammation leaves the mechanical malalignment untouched, so symptomatic improvement is inevitably limited. A peri-articular stem cell conditioned media injection for popliteus tendinopathy should be understood as a conservative option aimed at breaking the chronic inflammation cycle of the tendon and its enthesis, once structural problems have been excluded by diagnosis. Details on our treatment thinking are also available at this page on stem cell conditioned media joint injections.

Parallel exercise therapy and load management

Breaking the chronic cycle of popliteus tendinopathy requires load management and exercise therapy in parallel — not injections alone. Concretely, this means a temporary reduction in running volume, avoidance of downhill and uneven terrain, form review to reduce excessive knee and tibial internal rotation, and balanced strengthening of the gluteus medius, vastus medialis and triceps surae. Enthesis degeneration does not resolve in a few weeks, and even after an injection calms the inflammatory environment, load must be reintroduced in graded steps. Returning to full training simply because “the injection stopped the pain” often leads back into the recurrence and chronicity pattern. Position a peri-articular stem cell conditioned media injection realistically — as an accelerator built on top of the foundation of load management and rehabilitation.

Frequently Asked Questions

Q. Does popliteus tendinopathy occur in non-runners as well?

Yes. Running is the most frequent trigger, but it is also reported in hikers who frequently descend, in skiers and snowboarders during deceleration, and during cutting movements in soccer or rugby. Any sport that repeatedly loads the tibia into internal rotation with the knee flexed carries risk, and some patients find symptoms worsen on downhill commutes in daily life.

Q. How many peri-articular stem cell conditioned media injections are needed?

The number depends on the pathology, the degree of inflammation and the daily load that the patient reproduces, and it would not be honest to state a fixed number that “always works.” In many cases the protocol combines several injections during the induction phase, then spaces them out for maintenance based on the observed course. Response is judged over weeks to months using pain scores, symptom reproduction on running, and range of motion as objective measures.

Q. How does this differ from a local steroid injection?

Steroid injections powerfully suppress inflammatory mediators with rapid effect, but repeated use has been linked to tendon weakening and advancing enthesis degeneration. A peri-articular stem cell conditioned media injection targets anti-inflammatory action and repair-friendly conditions at the same time, which conceptually aligns with the pathology of popliteus tendinopathy — chronic inflammation and degeneration in a tendon-enthesis unit. That said, comparative trial evidence is still accumulating and we cannot declare one option universally superior.

Q. Can popliteus tendinopathy be diagnosed even when MRI is normal?

Yes. Chronic micro-degeneration of the popliteus tendon is not always visible as a clear signal change depending on MRI resolution and imaging protocol. A clinical diagnosis based on physical findings (localized tenderness, provocation tests) and symptom pattern (reproduction on descending running) is not unusual. When diagnosis is difficult, dynamic ultrasound assessment can be useful.

Q. When can I return to running after the injection?

There is considerable individual variation, but because a transient inflammatory reaction can appear immediately after injection, heavy loading should be avoided for the first several days. From there, progress step by step — starting with short flat jogs — while checking whether symptoms reproduce. Return to downhill running deserves particular caution and gradual re-exposure. Rushing back to the pre-injury training volume risks a return to the chronic pattern.

──────────────

Medical Supervisor: Dr. Shin Moriwaki

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate holder

──────────────

📍AVAN TOKYO Ginza Regenerative Medicine

AVAN TOKYO Ginza Regenerative Medicine

English / 中文 / Tiếng Việt available

For consultations, please contact us via DM / LINE / Website / Phone.